Repositorio digital RUNA

    • Español
    • Galego
    • English
  • Español 
    • Español
    • Galego
    • English
  • Login
RUNABibliosaúdeXunta de galicia. Consellería de sanidadeServicio Galego de saúde
  • REPOSITORIO
  • SOBRE NOSOTROS
    • Sobre RUNA
    • Normativa
    • Política Sergas
  • AYUDA
    • Ayuda
    • FAQ
  •   RUNA Principal
  • Navegar por autor
JavaScript is disabled for your browser. Some features of this site may not work without it.

Navegar por autor "Bello López, José Luis"

  • 0-9
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

Ordenar por:

Orden:

Resultados:

Mostrando ítems 1-20 de 32

  • título
  • fecha de publicación
  • fecha de envío
  • ascendente
  • descendente
  • 5
  • 10
  • 20
  • 40
  • 60
  • 80
  • 100
    • Thumbnail

      A phase 2 study from spanish geltamo group investigating the efficacy and safety of bendamustine as part of conditioning regimen for autologous stem-cell transplantation in patients with aggressive lymphomas: Second interim analysis 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      A point score simplification for practical use of the risk stratification for splenic marginal zone lymphoma based on hemoglobin, platelet count, high LDH level and extrahilar lymphadenopathy 

      2013- Bello López, José Luis
      Ver Item
    • Thumbnail

      A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia 

      2019- MOSQUERA ORGUEIRA, ADRIAN; Antelo Rodríguez, Beatriz; Díaz Arias, José; Díaz Varela, Nicolás; Bello López, José Luis [et al.]
      Ver Item
    • Thumbnail

      A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia. 

      2019-11-07- MOSQUERA ORGUEIRA, ADRIAN; Antelo Rodríguez, Beatriz; Díaz Arias, José; Díaz Varela, Nicolás; Bello López, José Luis [et al.]
      Ver Item
    • Thumbnail

      ANALYSIS OF THE EFFICACY OF PHOTOPHERESIS IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR CORTICODEPENDENT EICH: EXPERIENCE OF A CENTRE 

      2015- Bello López, José Luis; Vilariño López, María Dolores; Villamayor Álvarez, Mercedes; Campos Pena, Alfredo
      Ver Item
    • Thumbnail

      The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution 

      2019- MOSQUERA ORGUEIRA, ADRIAN; Antelo Rodríguez, Beatriz; Alonso Vence, Natalia; Díaz Arias, José; Díaz Varela, Nicolás; [et al.]
      Ver Item
    • Thumbnail

      Bendamustin as part of conditioning regimen for autologous stem cell transplantation (ASCT) in patients with aggressive lymphomas: A phase 2 study fromspanish geltamo group 

      2013- Bello López, José Luis
      Ver Item
    • Thumbnail

      Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group 

      2019- Redondo, A. M.; Valcárcel, D.; González-Rodríguez, A. P.; Suárez-Lledó, M.; Bello López, José Luis; [et al.]
      Ver Item
    • Thumbnail

      BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo) 

      2013- Bello López, José Luis
      Ver Item
    • Thumbnail

      Caspofungin for the treatment of invasive fungal disease in hematological patients (ProCAS Study) 

      2013- Debén Ariznavarreta, Guillermo; Bello López, José Luis
      Ver Item
    • Thumbnail

      Darbepoetin alfa administered once every three weeks for the treatment of anemia in elderly patients with non-myeloid tumors receiving chemotherapy 

      2014- Constenla Figueiras, Manuel; López López, Rafael; Bello López, José Luis
      Ver Item
    • Thumbnail

      DO WE STILL NEED THE ALKYLATORS AS PART OF THE UPFRONT-TREATMENT OF ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS? UPDATED FOLLOW-UP OF GEM2005MAS65 SPANISH TRIAL COMPARING VMP VS VTP AS INDUCTION 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      Do we still need the alkylators as part of the upfronttreatment of elderly newly diagnosed multiple myeloma patients? Updated follow-up of GEM2005MAS65 Spanish trial comparing VMP vs VTP as induction 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      First-line response-adapted treatment with the combination of bendamustine and rituximab in patients with mucosaassociated lymphoid tissue lymphoma (MALT2008-01): A multicentre, single-arm, phase 2 trial 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      GEM2005 trial update comparing VMP/VTP as induction in elderly multiple myeloma patients: do we still need alkylators? 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia 

      2019- MOSQUERA ORGUEIRA, ADRIAN; Antelo Rodríguez, Beatriz; Díaz Arias, José; Bello López, José Luis
      Ver Item
    • Thumbnail

      Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling 

      2020- MOSQUERA ORGUEIRA, ADRIAN; Díaz Arias, José; Cid López, Miguel; Peleteiro Raindo, Andrés; Antelo Rodríguez, Beatriz; [et al.]
      Ver Item
    • Thumbnail

      Influence of genetic polymorphisms in CYP1A2, CYP2C19, CYP3A4, GSTP1, MDR1 and PSMB5 genes in toxicity and response to induction therapy in multiple myeloma patients included in the trial of the Spanish PETHEMA/GEM 05 for newly diagnosed MM elderly patien 

      2011- Bello López, José Luis
      Ver Item
    • Thumbnail

      Intensification treatment based on early FDG-PET in patients with high-risk diffuse large B-cell lymphoma: a phase II GELTAMO trial 

      2014- Bello López, José Luis
      Ver Item
    • Thumbnail

      Maintenance therapy with bortezomib plus thalidomide or bortezomib plus prednisone in elderly multiple myeloma patients included in the GEM2005MAS65 trial 

      2012- Bello López, José Luis
      Ver Item

      Navega

      Todo RUNAColeccionesCentrosAutoresTítulosDeCSMeSHCIETipos de contenidos

      DE INTERÉS

      Sobre Acceso AbiertoDerechos de autor
      TwitterRSS
      Xunta de Galicia
      © Xunta de Galicia. Información mantida e publicada na internet pola Consellería de Sanidade o Servizo Galego de Saúde
      Aviso legal | RSS
      Galicia